Used in pharmaceutical synthesis as a key chiral intermediate for active pharmaceutical ingredients, particularly in the development of fluorinated drug candidates targeting central nervous system disorders and anti-inflammatory agents. Its difluorophenyl structure enhances metabolic stability and bioavailability, making it valuable in medicinal chemistry for optimizing lead compounds. Also employed in the preparation of selective enzyme inhibitors and receptor modulators in research settings.